NEW YORK (GenomeWeb) – The US Department of Veterans Affairs has launched a large, randomized clinical trial to assess whether using Myriad Genetics' GeneSight pharmacogenetic test helps get patients with major depressive disorder to the right treatment and improves their outcomes.